Infectious Dis. Medical News about Rapamycin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rapamycin: could it enhance vaccine efficacy
Expert Review of Vaccines, 11/02/09

Nam JH – It was reported recently that rapamycin, which is used as an immunosuppressive drug for organ transplantation, stimulates the production of memory CD8 T cells. This means that rapamycin or related drugs could be used to enhance the efficacy of many types of vaccines.

<< Previous
A case of acute transverse myelitis due to measles virus

Next >>
Immunoassays for the diagnosis of HIV: meeting future needs by...

Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients
Journal of Dermatological Science, 10/06/09 Relevance Score: 91%

Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs
Nephrology Dialysis Transplantation, 11/17/09 Relevance Score: 89%

Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis
International Journal of Cancer, 11/10/09 Relevance Score: 88%

MYC Activity Mitigates Response to Rapamycin in Prostate Cancer through Eukaryotic Initiation Factor 4E–Binding Protein 1–Mediated Inhibition of Autophagy
Cancer Research, 10/06/09 Relevance Score: 87%

Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML
European Journal of Internal Medicine, 11/06/09 Relevance Score: 85%